Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anticonvulsants for Alcohol Dependence and PTSD
NCT00571246Phase 3Withdrawn
- Sponsor
- Yale University
- Start
- Jun 2012
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alcohol dependence and post-traumatic stress disorder (PTSD) comparing Topiramate, Lamotrigine and Placebo (3 arms). Primary endpoints: Alcohol Consumption at 16 weeks, Alcohol Craving at 16 weeks and 1 more. Planned start Jun 2012; status: withdrawn.
02
Drugs
topiramatelamotrigine
03
Conditions
alcohol dependencepost-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00571246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00571246.